TALJA M[au] - Search Results

Year	Number of Results
1984	2
1985	4
1986	7
1987	3
1989	2
1990	2
1991	5
1992	3
1993	7
1994	4
1995	6
1996	4
1997	6
1998	2
1999	6
2000	7
2001	7
2002	7
2003	4
2004	1
2005	3
2006	3
2007	4
2008	3
2009	5
2010	1
2011	1
2012	3
2013	1
2017	1
2019	1
2020	1
2021	1
2026	0

1

Hämäläinen M, Nieminen R, Uurto I, Salenius JP, Kellomäki M, Mikkonen J, Kotsar A, Isotalo T, Teuvo Tammela LJ, Talja M, Moilanen E. Hämäläinen M, et al. Among authors: talja m. Basic Clin Pharmacol Toxicol. 2013 May;112(5):296-301. doi: 10.1111/bcpt.12056. Epub 2013 Mar 9. Basic Clin Pharmacol Toxicol. 2013. PMID: 23374962 Review.

2

Biodegradable urethral stents.

Tammela TL, Talja M. Tammela TL, et al. Among authors: talja m. BJU Int. 2003 Nov;92(8):843-50. doi: 10.1046/j.1464-410x.2003.04496.x. BJU Int. 2003. PMID: 14616434 Review. No abstract available.

3

Bioabsorbable and biodegradable stents in urology.

Talja M, Välimaa T, Tammela T, Petas A, Törmälä P. Talja M, et al. J Endourol. 1997 Dec;11(6):391-7. doi: 10.1089/end.1997.11.391. J Endourol. 1997. PMID: 9440846 Review.

4

[Renal oncocytoma].

Talja M, Bondestam S, Kivisaari L, Koivuniemi A, Mäkinen J, Lehtonen T. Talja M, et al. Duodecim. 1984;100(9):540-9. Duodecim. 1984. PMID: 6734474 Finnish. No abstract available.

5

Hydrophilic versus non-coated catheters for intermittent catheterization.

Hedlund H, Hjelmås K, Jonsson O, Klarskov P, Talja M. Hedlund H, et al. Among authors: talja m. Scand J Urol Nephrol. 2001 Feb;35(1):49-53. doi: 10.1080/00365590151030822. Scand J Urol Nephrol. 2001. PMID: 11291688 Review.

6

Eight-year post-trial follow-up of health care and long-term care costs of tele-based health coaching.

Mustonen E, Hörhammer I, Absetz P, Patja K, Lammintakanen J, Talja M, Kuronen R, Linna M. Mustonen E, et al. Among authors: talja m. Health Serv Res. 2020 Apr;55(2):211-217. doi: 10.1111/1475-6773.13251. Epub 2019 Dec 29. Health Serv Res. 2020. PMID: 31884682 Free PMC article. Clinical Trial.

7

Biochemical parameters as prognostic factors in prostatic adenocarcinoma.

Vesalainen S, Lipponen P, Talja M, Syrjänen K. Vesalainen S, et al. Among authors: talja m. Acta Oncol. 1995;34(1):53-9. doi: 10.3109/02841869509093639. Acta Oncol. 1995. PMID: 7865237

8

Eight-year post-trial follow-up of morbidity and mortality of telephone health coaching.

Mustonen E, Hörhammer I, Patja K, Absetz P, Lammintakanen J, Talja M, Kuronen R, Linna M. Mustonen E, et al. Among authors: talja m. BMC Health Serv Res. 2021 Nov 15;21(1):1237. doi: 10.1186/s12913-021-07263-w. BMC Health Serv Res. 2021. PMID: 34781936 Free PMC article. Clinical Trial.

9

Drug-eluting bioabsorbable stents - an in vitro study.

Mikkonen J, Uurto I, Isotalo T, Kotsar A, Tammela TL, Talja M, Salenius JP, Törmälä P, Kellomäki M. Mikkonen J, et al. Among authors: talja m. Acta Biomater. 2009 Oct;5(8):2894-900. doi: 10.1016/j.actbio.2009.03.039. Epub 2009 Apr 2. Acta Biomater. 2009. PMID: 19394906

10

Mitotic activity and prognosis in prostatic adenocarcinoma.

Vesalainen S, Lipponen P, Talja M, Syrjänen K. Vesalainen S, et al. Among authors: talja m. Prostate. 1995 Feb;26(2):80-6. doi: 10.1002/pros.2990260204. Prostate. 1995. PMID: 7855001

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Results by year

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

113 results

Results by year

Search Page

Filters

My Custom Filters

Results by year

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

113 results

Results by year